Publications

  1. Bulatao IG, Heckman MG, Rawal B, Aniskevich S, Shine TS, Keaveny AP, Perry DK, Canabal J, Willingham DL, Taner CB. Avoiding Stay in the Intensive Care Unit After Liver Transplantation: A Score to Assign Location of Care. Am J Transplant. 2014 Aug 01.
    View PubMed
  2. Sheikh-Ali M, Keaveny AP, Chamseddin A, Aguirre L, Clarke B, Meek S. 25-hydroxyvitamin d levels and acute cellular rejection in liver transplant patients. Endocr Pract. 2014 Aug 1; 20(8):769-74.
    View PubMed
  3. Wallace MB, Crook JE, Coe S, Ussui V, Staggs E, Almansa C, Patel MK, Bouras E, Cangemi J, Keaveny A, Picco M, Riegert-Johnson D. Accuracy of in vivo colorectal polyp discrimination by using dual-focus high-definition narrow-band imaging colonoscopy. Gastrointest Endosc. 2014 Jun 24.
    View PubMed
  4. Wadei HM, Heckman MG, Rawal B, Taner CB, Mai ML, Cortese C, Rosser BG, Gonwa TA, Keaveny AP. Renal Outcomes of Liver Transplant Recipients Who Had Pretransplant Kidney Biopsy. Transplantation. 2014 Jun 12.
    View PubMed
  5. Wadei HM, Bulatao IG, Gonwa TA, Mai ML, Prendergast M, Keaveny AP, Rosser BG, Taner CB. Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: Single-center and organ procurement and transplantation network analyses. Liver Transpl. 2014 Jun; 20(6):728-35.
    View PubMed
  6. Bulatao IG, Heckman MG, Rawal B, Aniskevich S, Shine TS, Keaveny AP, Perry DK, Canabal J, Willingham DL, Taner CB. Avoiding stay in the intensive care unit after liver transplantation: A score to assign location of care. Am J Transplant. 2014; 14(9):2088-96.
  7. Crespo S, Bridges M, Nakhleh R, McPhail A, Pungpapong S, Keaveny AP. Non-invasive assessment of liver fibrosis using magnetic resonance elastography in liver transplant recipients with hepatitis C. Clin Transplant. 2013 Sep-Oct; 27(5):652-8. Epub 2013 Jul 10.
    View PubMed
  8. Pungpapong S, Aqel BA, Koning L, Murphy JL, Henry TM, Ryland KL, Yataco ML, Satyanarayana R, Rosser BG, Vargas HE, Charlton MR, Keaveny AP. Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation. Liver Transpl. 2013 Jul; 19(7):690-700. Epub 2013 Jun 03.
    View PubMed
  9. Wadei HM, Zaky ZS, Keaveny AP, Rosser B, Jones M, Mai ML, Bulatao I, Gonwa TA. Proteinuria following sirolimus conversion is associated with deterioration of kidney function in liver transplant recipients. Transplantation. 2012 May 27; 93(10):1006-12.
    View PubMed
  10. Taner CB, Bulatao IG, Willingham DL, Perry DK, Sibulesky L, Pungpapong S, Aranda-Michel J, Keaveny AP, Kramer DJ, Nguyen JH. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl. 2012 Jan; 18(1):100-11.
    View PubMed
  11. Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl. 2011 Jun; 17(6):641-9.
    View PubMed
  12. Dickson RC, Pungpapong S, Keaveny AP, Taner CB, Ghabril M, Aranda-Michel J, Satyanarayana R, Bonatti H, Kramer DJ, Nguyen JH. Improving graft survival for patients undergoing liver transplantation. Clin Transplant. 2011 May-Jun; 25(3):E345-55. Epub 2011 Mar 23.
    View PubMed
  13. Taner CB, Balci D, Willingham DL, Keaveny AP, Rosser BG, Canabal JM, Shine TS, Harnois DM, Kramer DJ, Nguyen JH. Long-term outcomes after third liver transplant. Exp Clin Transplant. 2011 Apr; 9(2):98-104.
    View PubMed
  14. Begum R, Harnois D, Satyanarayana R, Krishna M, Halling KC, Kim GP, Nguyen JH, Keaveny AP. Retransplantation for donor-derived neuroendocrine tumor. Liver Transpl. 2011 Jan; 17(1):83-7.
    View PubMed
  15. Hughes CB, Dickson RC, Krishna M, Willingham DL, Satyanarayana R, Harnois DM, Keaveny AP, Rosser B, Aranda-Michel J, Kramer DJ, Hellinger W, Mendez J. HCV recurrence in HIV-infected patients after liver transplant. J Int Assoc Physicians AIDS Care (Chic). 2010 Mar-Apr; 9(2):87-93. Epub 2010 Mar 31.
    View PubMed
  16. Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, Rosser BG, Keaveny AP, Aranda-Michel J, Satyanarayana R, Harnois D, Dickson RC, Kramer DJ, Hughes CB. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl. 2009 Sep; 15(9):1028-35.
    View PubMed
  17. Gill KR, Pelaez-Luna M, Keaveny A, Woodward TA, Wallace MB, Chari ST, Smyrk TC, Takahashi N, Clain JE, Levy MJ, Pearson RK, Petersen BT, Topazian MD, Vege SS, Kendrick M, Farnell MB, Raimondo M. Branch duct intraductal papillary mucinous neoplasm of the pancreas in solid organ transplant recipients. Am J Gastroenterol. 2009 May; 104(5):1256-61. Epub 2009 Apr 07.
    View PubMed
  18. Ghabril M, Dickson RC, Krishna M, Bonatti H, Aranda-Michel J, Keaveny AP, Satyanarayana R, Hewitt W, Hughes CB, Nguyen JH. Liver transplantation using young pediatric donor grafts in adults with hepatitis C infection. Transplantation. 2009 Apr 27; 87(8):1174-9.
    View PubMed
  19. Nguyen JH, Bonatti H, Dickson RC, Hewitt WR, Grewal HP, Willingham DL, Harnois DM, Schmitt TM, Machicao VI, Ghabril MS, Keaveny AP, Aranda-Michel J, Satyanarayana R, Rosser BG, Hinder RA, Steers JL, Hughes CB. Long-term outcomes of donation after cardiac death liver allografts from a single center. Clin Transplant. 2009 Mar-Apr; 23(2):168-73. Epub 2009 Feb 11.
    View PubMed
  20. Ghabril M, Dickson RC, Krishna M, Lloyd R, Aranda-Michel J, Keaveny A, Satyanarayana R, Bonatti H. Persistence of hepatitis C RNA in liver allografts is associated with histologic progression independent of serologic viral clearance. J Transplant. 2009; 2009:297528. Epub 2009 May 05.
    View PubMed
  21. Keaveny AP, Sigal SS. Effect of Hepatorenal syndrome resolution on transplant and transplant-free outcomes. US Gastroenterology and Hepatology Review. 2009; 5:31-36.
  22. Wadei HM, Geiger XJ, Cortese C, Mai ML, Kramer DJ, Rosser BG, Keaveny AP, Willingham DL, Ahsan N, Gonwa TA. Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy. Am J Transplant. 2008 Dec; 8(12):2618-26.
    View PubMed
  23. Pungpapong S, Nunes DP, Krishna M, Nakhleh R, Chambers K, Ghabril M, Dickson RC, Hughes CB, Steers J, Nguyen JH, Keaveny AP. Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C. Liver Transpl. 2008 Sep; 14(9):1294-302.
    View PubMed
  24. Aranda-Michel J, Dickson RC, Bonatti H, Crossfield JR, Keaveny AP, Vasquez AR. Patient selection for liver transplant: 1-year experience with 555 patients at a single center. Mayo Clin Proc. 2008 Feb; 83(2):165-8.
    View PubMed
  25. Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival. Liver Transpl. 2007 Dec; 13(12):1717-27.
    View PubMed
  26. Pungpapong S, Keaveny A, Raimondo M, Dickson R, Woodward T, Harnois D, Wallace M. Accuracy and interobserver agreement of small-caliber vs. conventional esophagogastroduodenoscopy for evaluating esophageal varices. Endoscopy. 2007 Aug; 39(8):673-80. Epub 2007 Jun 22.
    View PubMed
  27. Pungpapong S, Alvarez S, Hellinger WC, Kramer DJ, Willingham DL, Mendez JC, Nguyen JH, Hewitt WR, Aranda-Michel J, Harnois DM, Rosser BG, Hughes CB, Grewal HP, Satyanarayana R, Dickson RC, Steers JL, Keaveny AP. Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome. Liver Transpl. 2006 Aug; 12(8):1244-52.
    View PubMed
  28. Pungpapong S, Steers JL, Wallace MB, Krishna M, Keaveny AP. Hepatobiliary sarcoidosis mimicking Klatskin's cholangiocarcinoma. Gastrointest Endosc. 2006 Jul; 64(1):124-5.
    View PubMed
  29. Pungpapong S, Krishna M, Abraham SC, Keaveny AP, Dickson RC, Nakhleh RE. Clinicopathologic findings and outcomes of liver transplantation using grafts from donors with unrecognized and unusual diseases. Liver Transpl. 2006 Feb; 12(2):310-5.
    View PubMed
  30. Krishna M, Keaveny AP, Genco PV, Rosser BG, Dickson RC, Nguyen JH, Steers JL, Nakhleh RE. Clinicopathological review of 18 cases of liver allografts lost due to bile duct necrosis. Transplant Proc. 2005 Jun; 37(5):2221-3.
    View PubMed
  31. Nakhleh RE, Krishna M, Keaveny AP, Dickson RC, Rosser B, Nguyen JH, Steers JL. Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence. Transplant Proc. 2005 Mar; 37(2):1240-2.
    View PubMed
  32. Keaveny AP, Gordon FD, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, Jenkins RL, Khettry U. Native liver xanthogranulomatous cholangiopathy in primary sclerosing cholangitis: impact on posttransplant outcome. Liver Transpl. 2004 Jan; 10(1):115-22.
    View PubMed
  33. Khettry U, Keaveny A, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, Jenkins RL, Gordon FD. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study. Hum Pathol. 2003 Nov; 34(11):1127-36.
    View PubMed
  34. O'Brien MJ, Keating NM, Elderiny S, Cerda S, Keaveny AP, Afdhal NH, Nunes DP. An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. Am J Clin Pathol. 2000 Nov; 114(5):712-8.
    View PubMed
  35. Keaveny AP, Offner GD, Bootle E, Nunes DP. No significant difference in antigenicity or tissue transglutaminase substrate specificity of Irish and US wheat gliadins. Dig Dis Sci. 2000 Apr; 45(4):755-62.
    View PubMed
  36. Keaveny AP, Karasik MS, Farber HW. Successful treatment of chylous ascites secondary to Mycobacterium avium complex in a patient with the acquired immune deficiency syndrome. Am J Gastroenterol. 1999 Jun; 94(6):1689-90.
    View PubMed
  37. Keaveny AP, Karasik MS. Hepatobiliary and pancreatic infections in AIDS: Part II. AIDS Patient Care STDS. 1998 Jun; 12(6):451-6.
    View PubMed
  38. Keaveny AP, Karasik MS. Hepatobiliary and pancreatic infections in AIDS: Part one. AIDS Patient Care STDS. 1998 May; 12(5):347-57.
    View PubMed
  39. Afdhal NH, Keaveny AP, Cohen SB, Nunes DP, Maldonado N, O'Brien M, Stone PJ. Urinary assays for desmosine and hydroxylysylpyridinoline in the detection of cirrhosis. J Hepatol. 1997 Dec; 27(6):993-1002.
    View PubMed
  40. Salomons H, Keaveny AP, Henihan R, Offner G, Sengupta A, Lamorte WW, Afdhal NH. Nitric oxide and gallbladder motility in prairie dogs. Am J Physiol. 1997 Apr; 272(4 Pt 1):G770-8.
    View PubMed
  41. Keaveny AP, Freaney R, McKenna MJ, Masterson J, O'Donoghue DP. Bone remodeling indices and secondary hyperparathyroidism in celiac disease. Am J Gastroenterol. 1996 Jun; 91(6):1226-31.
    View PubMed